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Biophysical Journal Volume 107 July 2014 287–288 287New and NotableFIGURE 1 Changes in allosteric communication upon agonist binding. Dominant allosteric pathways
in the inactive state are illustrated by the red arrows. The binding of agonist results in a distinct
shift in allosteric pathways, as illustrated by the green arrows. Figure provided by Bhattacharya and
Vaidehi (2). To see this figure in color, go online.New Pipelines for Novel
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Hormonal, neurotransmitter, visual,
and olfactory signaling is largely regu-
lated by a versatile class of membrane
receptors, referred to as G-protein
coupled receptors (GPCRs). Humans
possess at least 800 distinct GPCRs,
and, not surprisingly, 40% of current
pharmaceuticals are meant to directly
target GPCRs (1). However, the phar-
macology of GPCRs has never been
easy to understand, and phenomena
such as constitutive activity, biased
agonism, partial and full agonism,
and allostery speak to the complexity
and versatility of these receptors.
The paper by Bhattacharya and Vai-
dehi (2), in this issue of Biophysical
Journal, addresses some of these com-
plexities by examining the mecha-
nisms of activation through analysis
of molecular dynamics (MD) trajec-
tories. Activation of GPCRs cannot
currently be observed by all-atom
MD. However, it is possible to
monitor MD trajectories of GPCRs
for tens of microseconds. This was
accomplished earlier by the D.E.
Shaw group (3,4), which identified
an inactive, activation intermediate,
and active state, starting from either
the inactive or active crystal structures
of the adrenergic receptor, b2AR.
Bhattacharya and Vaidehi (2) make
use of MD trajectories associated
with these states and analyze torsional
angle correlations in the spirit of
earlier work on soluble proteins by
Pandini et al. (5).http://dx.doi.org/10.1016/j.bpj.2014.06.016
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terminal residues, distinct allosteric
pathways can be identified from an
analysis of torsional angle correlations
in the above MD trajectories. Remark-
ably, these pathways prove to be
grossly different in the inactive, activa-
tion intermediate, and active states. By
considering overlap and common hubs
through which information is propa-
gated, these pathways can be further
grouped or clustered into pipelines.
Binding of an agonist results in resi-
dues in the vicinity of the orthosteric
binding site serving as initiators of
allosteric communication, where there
is observed to be an increased correla-
tion between these residues, the extra-
cellular loops, and both intracellular
and extracellular transmembrane do-
mains (Fig. 1). In the intermediate
state, the top half of the receptor be-
comes effectively decoupled from the
G protein binding domain, and the
G protein interface of the receptor be-
comes more dynamic. The active state
acquires new pipelines, some of which
are thought to reinforce specific inter-
actions between the G protein and
receptor.
The above approach can be corrobo-
rated by examining the effects of two
kinds of mutations on pipelines (i.e.,those mutations that increase agonist
binding and activation and those that
suppress activation). Invariably, the
majority of activating mutations tend
to lie along allosteric pipelines in
the inactive state, whereas inactivating
mutations are associated with allo-
steric pipelines in the active state.
Although this analysis helps us
to understand activation mechanisms
and the role of allosteric clusters,
it also suggests a strategy for the
design of allosteric pharmacophores
with novel activity, which is an impor-
tant area of study in GPCR pharma-
cology (6,7). The orthosteric binding
site is known to be highly conserved
among very functionally diverse class
A GPCRs. Therefore, an allosteric
ligand that perturbs a hub residue
outside the orthosteric pocket might
specifically modify/regulate the activ-
ity of a given receptor. The authors
point to pockets along allosteric pipe-
lines, which might be ideal for allo-
steric drug design. In any case, this
computational approach seems fruitful
in terms of knitting together structural
and dynamical information on GPCRs
and understanding their function.
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